A revised structure of the antitumor drug elliptinium — Amino(acid) adducts
- 1 September 1985
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 131 (2), 614-619
- https://doi.org/10.1016/0006-291x(85)91281-1
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Accessibility to bacterial nucleic acids of the intercalating drug aliphatic amino acid-ellipticinium derivatives in Escherichia coli and Salmonella typhimuriumBiochemistry, 1985
- Reinvestigation of the reaction of n-2-methyl-9-hydroxyellipticinium acetate with adenosine and methanol.Tetrahedron Letters, 1984
- Potential antitumor agents: synthesis and biological properties of aliphatic amino acid 9-hydroxyellipticinium derivativesJournal of Medicinal Chemistry, 1984
- Unexpected regiospecific alkylation of the antitumor agent N2-methyl-9-hydroxyellipticinium acetate with N, O or S donorsTetrahedron Letters, 1983
- Peroxidase-catalysed covalent binding of the antitumor drug 2N-methyl-9-hydroxy-ellipticine to proteinsBiochemical Pharmacology, 1983
- Pharmacokinetics of 2-methyl-9-hydroxyellipticinium acetate (NSC-264137) in cancer patients (phase I study)European Journal of Cancer and Clinical Oncology, 1982
- Antitumor Activity, Pharmacology, and Toxicity of Ellipticines, Ellipticinium, and 9-Hydroxy Derivatives: Preliminary Clinical Trials of 2-Methyl-9-Hydroxy Ellipticinium (NSC 264-137)Published by Springer Nature ,1980